new cancer drug, Gleevec

There's a lot of excitement about the new cancer drug, Gleevec.

Gleevec is approved for treating chronic myeloid leukemia (CML)...but it might also be useful for other types of cancer.

Gleevec (imatinib) is the first of a new class of designer drugs that specifically targets cancer cells.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote